SK287653B6 - Nevodná farmaceutická kompozícia na dermálne použitie - Google Patents
Nevodná farmaceutická kompozícia na dermálne použitie Download PDFInfo
- Publication number
- SK287653B6 SK287653B6 SK1518-2001A SK15182001A SK287653B6 SK 287653 B6 SK287653 B6 SK 287653B6 SK 15182001 A SK15182001 A SK 15182001A SK 287653 B6 SK287653 B6 SK 287653B6
- Authority
- SK
- Slovakia
- Prior art keywords
- composition
- component
- calcipotriol
- vitamin
- group
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Nutrition Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA199900561 | 1999-04-23 | ||
PCT/DK2000/000033 WO2000064450A1 (en) | 1999-04-23 | 2000-01-27 | Pharmaceutical composition |
Publications (2)
Publication Number | Publication Date |
---|---|
SK15182001A3 SK15182001A3 (sk) | 2002-06-04 |
SK287653B6 true SK287653B6 (sk) | 2011-05-06 |
Family
ID=8094933
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK1518-2001A SK287653B6 (sk) | 1999-04-23 | 2000-01-27 | Nevodná farmaceutická kompozícia na dermálne použitie |
Country Status (30)
Country | Link |
---|---|
US (1) | US6753013B1 (lt) |
EP (5) | EP2450043B1 (lt) |
JP (4) | JP4426729B2 (lt) |
KR (1) | KR100694526B1 (lt) |
CN (1) | CN1173703C (lt) |
AU (1) | AU774600B2 (lt) |
BG (1) | BG65115B1 (lt) |
BR (3) | BR122012030847B1 (lt) |
CA (1) | CA2370565C (lt) |
CY (5) | CY1113967T1 (lt) |
CZ (1) | CZ303142B6 (lt) |
DK (5) | DK1178808T4 (lt) |
ES (5) | ES2388425T5 (lt) |
HK (1) | HK1045650B (lt) |
HR (1) | HRP20010779B1 (lt) |
HU (1) | HU230045B1 (lt) |
IL (2) | IL145983A0 (lt) |
IS (1) | IS6120A (lt) |
LT (2) | LT2915534T (lt) |
ME (1) | ME00298B (lt) |
MX (1) | MXPA01010676A (lt) |
NO (1) | NO329486B1 (lt) |
NZ (1) | NZ515142A (lt) |
PL (1) | PL199123B1 (lt) |
PT (5) | PT2450043T (lt) |
RS (1) | RS52182B (lt) |
RU (1) | RU2238734C2 (lt) |
SI (3) | SI2915534T1 (lt) |
SK (1) | SK287653B6 (lt) |
WO (1) | WO2000064450A1 (lt) |
Families Citing this family (100)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8263580B2 (en) * | 1998-09-11 | 2012-09-11 | Stiefel Research Australia Pty Ltd | Vitamin formulation |
HU230045B1 (hu) | 1999-04-23 | 2015-06-29 | Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) | Bőrgyógyászati alkalmazásra szolgáló nem vizes gyógyszerkészítmény |
US20090098065A1 (en) * | 2000-01-11 | 2009-04-16 | Avikam Harel | Composition and methods for the treatment of skin disorders |
PT1330468E (pt) * | 2000-09-18 | 2007-09-13 | Serono Lab | Análogos de enxofre de 21-hidroxi-6, 19-oxidoprogesterona ( 21oh-60p) para tratar excesso de glucocorticóides. |
MXPA03003511A (es) | 2000-10-27 | 2004-05-04 | Leo Pharma As | Composicion topica que contiene al menos una vitamina d o un analogo de vitamina de y al menos un corticosteroide. |
US20090143328A1 (en) * | 2001-08-13 | 2009-06-04 | Mcdonald George | Method of Treating Cancer by Administration of Topical Active Corticosteroids |
US20030175314A1 (en) * | 2001-11-19 | 2003-09-18 | Didriksen Erik Johannes | Pharmaceutical composition for dermal application |
IL152486A0 (en) | 2002-10-25 | 2003-05-29 | Meir Eini | Alcohol-free cosmetic and pharmaceutical foam carrier |
US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
US7704518B2 (en) | 2003-08-04 | 2010-04-27 | Foamix, Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
US20080031907A1 (en) * | 2002-10-25 | 2008-02-07 | Foamix Ltd. | Cosmetic and pharmaceutical foam |
ES2532906T5 (es) | 2002-10-25 | 2022-03-23 | Foamix Pharmaceuticals Ltd | Espuma cosmética y farmacéutica |
US8900554B2 (en) | 2002-10-25 | 2014-12-02 | Foamix Pharmaceuticals Ltd. | Foamable composition and uses thereof |
US7700076B2 (en) | 2002-10-25 | 2010-04-20 | Foamix, Ltd. | Penetrating pharmaceutical foam |
US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
US7820145B2 (en) | 2003-08-04 | 2010-10-26 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
US20080138296A1 (en) * | 2002-10-25 | 2008-06-12 | Foamix Ltd. | Foam prepared from nanoemulsions and uses |
US10117812B2 (en) * | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
US20050101576A1 (en) * | 2003-11-06 | 2005-05-12 | Novacea, Inc. | Methods of using vitamin D compounds in the treatment of myelodysplastic syndromes |
EP1458678A1 (en) * | 2002-11-18 | 2004-09-22 | Teva Pharmaceutical Industries Limited | A crystallization method for purification of calcipotriene |
FR2848454B1 (fr) * | 2002-12-17 | 2007-03-30 | Galderma Res & Dev | Composition pharmaceutique comprenant une association de calcitriol et d'un corticosteroide |
EP1854466A1 (en) * | 2002-12-17 | 2007-11-14 | Galderma Research & Development, S.N.C. | Pharmaceutical composition comprising a combination of calcitriol and clobetasol propionate |
RU2361594C2 (ru) * | 2002-12-17 | 2009-07-20 | Галдерма Са | Фармацевтические композиции, включающие комбинацию кальцитриола и клобетазола пропионат |
JP2004359585A (ja) * | 2003-06-03 | 2004-12-24 | Medorekkusu:Kk | 被膜形成型の副腎皮質ステロイド薬含有外用製剤 |
FR2856301B1 (fr) | 2003-06-23 | 2007-08-03 | Galderma Res & Dev | Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile |
US8795693B2 (en) | 2003-08-04 | 2014-08-05 | Foamix Ltd. | Compositions with modulating agents |
AR045241A1 (es) * | 2003-08-12 | 2005-10-19 | Novartis Consumer Health Sa | Composicion topica que comprende terbinafina e hidrocortisona |
US8025899B2 (en) | 2003-08-28 | 2011-09-27 | Abbott Laboratories | Solid pharmaceutical dosage form |
US8404667B2 (en) * | 2006-12-29 | 2013-03-26 | Wisconsin Alumni Research Foundation | Compounds, compositions, kits and methods of use to orally and topically treat acne and other skin conditions by 19-Nor vitamin D analog |
CA2567099A1 (en) * | 2004-05-26 | 2005-12-08 | Cedars-Sinai Medical Center | Induction of innate immunity by vitamin d3 and its analogs |
FR2871698B1 (fr) * | 2004-06-17 | 2008-07-04 | Galderma Sa | Composition sous forme de spray comprenant une association d'actifs pharmaceutiques et une phase huileuse |
FR2871693B1 (fr) * | 2004-06-17 | 2006-08-25 | Galderma Sa | Utilisation d'une composition pharmaceutique comprenant du calcitriol et du propionate de clobetasol pour le traitement du psoriasis |
KR20070027587A (ko) * | 2004-06-17 | 2007-03-09 | 갈데르마 소시에떼아노님 | 실리콘제, 코르티코스테로이드 및 비타민 d 또는 이의유도체를 함유하는 건선 치료용 조성물 |
FR2871695B1 (fr) | 2004-06-17 | 2008-07-04 | Galderma Sa | Composition pharmaceutique comprenant un agent silicone et deux principes actifs solubilises |
FR2871700B1 (fr) * | 2004-06-17 | 2006-11-17 | Galderma Sa | Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, et une phase huileuse |
JP2008502646A (ja) * | 2004-06-17 | 2008-01-31 | ガルデルマ・ソシエテ・アノニム | プロピオン酸クロベタゾールとカルシトリオールとの組合せ、アルコール相、および油性相を含むスプレーの形態の組成物 |
BRPI0511389A (pt) * | 2004-06-17 | 2007-12-04 | Galderma Sa | composição e seu uso |
FR2871697B1 (fr) * | 2004-06-17 | 2007-06-29 | Galderma Sa | Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, au moins un silicone volatile et une phase huileuse non volatile |
FR2871694B1 (fr) * | 2004-06-17 | 2008-07-04 | Galderma Sa | Composition pharmaceutique comprenant un onguent oleagineux et deux principes actifs solubilises |
FR2871699A1 (fr) * | 2004-06-17 | 2005-12-23 | Galderma Sa | Composition de type emulsion inverse contenant du calcitrol et du 17-propionate de clobetasol, et ses utilisations en cosmetiques et en dermatologie |
FR2871696B1 (fr) * | 2004-06-17 | 2006-11-10 | Galderma Sa | Composition topique pour le traitement du psoriasis |
JP2006131544A (ja) * | 2004-11-05 | 2006-05-25 | Medorekkusu:Kk | 皮膚疾患治療用外用剤 |
EP1828113B1 (en) * | 2004-11-22 | 2010-05-12 | Wisconsin Alumni Research Foundation | 2-methylene-19,26,27-trinor-(20s)-1-alpha-hydroxyvitamin d3 and its uses |
FR2884419B1 (fr) * | 2005-04-19 | 2007-06-22 | Galderma Sa | Composition de type solution filmogene comprenant de la vitamine d ou un de ses derives et un corticosteroide, et son utilisation en dermatologie |
EP1874320A1 (en) * | 2005-04-19 | 2008-01-09 | Galderma S.A. | Composition of film-forming solution type, comprising vitamin d or a derivative thereof and a corticosteroid, and use thereof in dermatology |
ZA200710371B (en) * | 2005-05-10 | 2009-07-29 | Dermipsor Ltd | Compositions and methods for treating hyperproliferative epidermal diseases |
US8034788B2 (en) * | 2005-05-10 | 2011-10-11 | Dermipsor Ltd. | Composition and methods for skin care |
EP2526930B1 (en) * | 2005-06-01 | 2013-12-25 | GlaxoSmithKline Intellectual Property Development Limited | Vitamin formulation |
US20080152596A1 (en) * | 2005-07-19 | 2008-06-26 | Foamix Ltd. | Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof |
RU2412165C2 (ru) | 2006-03-17 | 2011-02-20 | Лео Фарма А/С | Изомеризация фармацевтических интермедиатов |
BRPI0715636A2 (pt) * | 2006-08-29 | 2013-07-02 | Teva Pharma | composiÇÕes farmacologicamente ativas estÁveis incluindo compostos contendo vitamina d e corticosteràide com compatibilidade para ph baixo |
EP2069296B1 (en) * | 2006-09-28 | 2012-04-04 | Wisconsin Alumni Research Foundation | 2-methylene-(20s,25s)-19,27-dinor-(22e)-vitamin d analogs |
AU2007300214A1 (en) * | 2006-09-28 | 2008-04-03 | Wisconsin Alumni Research Foundation | 2-methylene-(20R,25S)-19,27-dinor-(22E)-vitamin D analogs |
US20080260655A1 (en) | 2006-11-14 | 2008-10-23 | Dov Tamarkin | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
FR2909284B1 (fr) * | 2006-11-30 | 2012-09-21 | Galderma Sa | Nouvelles compositions sous forme d'onguent sans vaseline comprenant un derive de vitamine d et eventuellement un anti-inflammatoire steroidien |
ES2272198B1 (es) * | 2006-12-28 | 2008-06-01 | Laboratorios Viñas S.A. | Procedimiento para la obtencion de hidrato de calcipotriol. |
US10265265B2 (en) * | 2007-03-15 | 2019-04-23 | Drug Delivery Solutions Limited | Topical composition |
EP1970049A1 (en) * | 2007-03-15 | 2008-09-17 | Drug Delivery Solutions Limited | Polyaphron topical composition with vitamin D and corticosteroid |
EP1970048A1 (en) * | 2007-03-15 | 2008-09-17 | Drug Delivery Solutions Limited | Polyaphron topical composition with vitamin D |
EP2008651A1 (en) | 2007-06-26 | 2008-12-31 | Drug Delivery Solutions Limited | A bioerodible patch |
HU227970B1 (en) | 2007-07-10 | 2012-07-30 | Egis Gyogyszergyar Nyrt | Pharmaceutical compositions containing silicones of high volatility |
US8636982B2 (en) | 2007-08-07 | 2014-01-28 | Foamix Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
WO2009069006A2 (en) * | 2007-11-30 | 2009-06-04 | Foamix Ltd. | Foam containing benzoyl peroxide |
WO2009072007A2 (en) | 2007-12-07 | 2009-06-11 | Foamix Ltd. | Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof |
US20090192228A1 (en) * | 2008-01-28 | 2009-07-30 | Actavis Group Ptc Ehf | Controlled-Release Tolterodine Compositions and Methods |
NZ592300A (en) * | 2008-10-03 | 2013-01-25 | Nexmed Holdings Inc | Stabilized composition for treating psoriasis |
CA2760186C (en) | 2009-04-28 | 2019-10-29 | Foamix Ltd. | Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
US20100286101A1 (en) * | 2009-05-07 | 2010-11-11 | Jason Carbol | Pharmaceutical composition including a corticosteroid and a vitamin d analog having improved stability |
CA2769677A1 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
CA2769625C (en) | 2009-07-29 | 2017-04-11 | Foamix Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
US20110053898A1 (en) * | 2009-08-26 | 2011-03-03 | Glenmark Generics Ltd | Topical composition comprising vitamin d analogue and corticosteroids |
KR20120104975A (ko) | 2009-10-01 | 2012-09-24 | 앱탈리스 파마테크, 인코포레이티드 | 경구 투여용 코르티코스테로이드 조성물 |
US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
US8871184B2 (en) | 2009-10-02 | 2014-10-28 | Foamix Ltd. | Topical tetracycline compositions |
BR112012015437A2 (pt) * | 2009-12-22 | 2016-03-15 | Leo Pharma As | composição tópica substancialmente anidra de armazenamento estável |
KR101619077B1 (ko) | 2010-06-11 | 2016-05-10 | 레오 파마 에이/에스 | 비타민 d 유사체 및 코르티코스테로이드를 포함하는 약제학적 분무 조성물 |
US8685381B2 (en) | 2010-10-23 | 2014-04-01 | Joel Schlessinger | Topical base and active agent-containing compositions, and methods for improving and treating skin |
US8968755B2 (en) | 2010-10-23 | 2015-03-03 | Joel Schlessinger | Topical base and active agent-containing compositions, and methods for improving and treating skin |
JP6105494B2 (ja) | 2011-03-14 | 2017-03-29 | ドラッグ デリバリー ソリューションズ リミテッド | 眼科用組成物 |
US11154535B2 (en) | 2012-07-31 | 2021-10-26 | Egis Pharmaceuticals Plc | Transdermal formulation containing COX inhibitors |
US10045935B2 (en) | 2012-07-31 | 2018-08-14 | Egis Pharmaceuticals Plc | Transdermal formulation containing COX inhibitors |
CN103110648A (zh) * | 2013-01-25 | 2013-05-22 | 江苏圣宝罗药业有限公司 | 钙泊三醇倍他米松软膏及其制备方法 |
EP2951164B1 (en) | 2013-01-29 | 2019-06-05 | Avexxin AS | Antiinflammatory and antitumor 2-oxothiazoles compounds |
WO2015034678A2 (en) | 2013-09-06 | 2015-03-12 | Aptalis Pharmatech, Inc. | Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis |
CN104666312B (zh) * | 2015-02-12 | 2017-11-07 | 重庆华邦制药有限公司 | 含有卡泊三醇和二丙酸倍他米松的制剂 |
MA41818A (fr) * | 2015-03-27 | 2018-01-30 | Leo Pharma As | Timbre à micro-aiguilles pour administration d'un principe actif à la peau |
TW201636025A (zh) * | 2015-04-15 | 2016-10-16 | Maruho Kk | 皮膚用之醫藥組成物 |
KR101641372B1 (ko) * | 2015-05-08 | 2016-07-20 | (주)동구바이오제약 | 안정성과 피부투과율이 향상된 약학 조성물 |
CN107157919B (zh) * | 2016-03-08 | 2019-12-27 | 上海通用药业股份有限公司 | 一种用于治疗银屑病的半固体制剂的制备方法 |
CN107157917B (zh) * | 2016-03-08 | 2019-12-27 | 上海通用药业股份有限公司 | 一种用于治疗银屑病的软膏的制备方法 |
CN107157918B (zh) * | 2016-03-08 | 2019-12-27 | 上海通用药业股份有限公司 | 一种用于银屑病治疗的半固体制剂的制备方法 |
CN107157920B (zh) * | 2016-03-08 | 2019-12-27 | 上海通用药业股份有限公司 | 一种包含维生素d或其衍生物的半固体制剂的制备方法 |
GB201604318D0 (en) | 2016-03-14 | 2016-04-27 | Avexxin As | Combination therapy |
TWI777515B (zh) | 2016-08-18 | 2022-09-11 | 美商愛戴爾製藥股份有限公司 | 治療嗜伊紅性食道炎之方法 |
CA2978573A1 (en) | 2016-09-08 | 2018-03-08 | Foamix Pharmaceuticals Ltd. | Compositions and methods for treating rosacea and acne |
WO2019072353A1 (en) * | 2017-10-11 | 2019-04-18 | Elmasry Mohamed Zakria Ahmed Ali | TOPICAL PHARMACEUTICAL PREPARATION OF BETAMETHASONE, CALCIPOTRIOL AND ROSE OIL FOR THE TREATMENT OF PSORIASIS |
EP3542788A1 (en) | 2018-03-19 | 2019-09-25 | MC2 Therapeutics Limited | Topical composition comprising calcipotriol and betamethasone dipropionate |
FR3083701B1 (fr) | 2018-07-13 | 2020-08-14 | Gifrer Barbezat | Liniment oleo-alcalin |
JP7350985B2 (ja) * | 2020-03-19 | 2023-09-26 | シオノギヘルスケア株式会社 | ベタメタゾン吉草酸エステル含有組成物 |
CN115177586A (zh) * | 2022-08-31 | 2022-10-14 | 江苏知原药业股份有限公司 | 一种卡泊三醇组合物 |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB892127A (en) * | 1958-03-03 | 1962-03-21 | Merck & Co Inc | Therapeutic preparations comprising steroids and vitamin d |
DK116528A (lt) * | 1966-09-30 | |||
US4083974A (en) | 1977-03-07 | 1978-04-11 | The Upjohn Company | Topical steroidal anti-inflammatory preparations containing polyoxypropylene 15 stearyl ether |
JPS59139315A (ja) * | 1983-01-31 | 1984-08-10 | Taisho Pharmaceut Co Ltd | クリ−ム剤 |
US4569935A (en) * | 1983-03-17 | 1986-02-11 | University Of Tennessee Research Corp. | Topical treatment of psoriasis with imidazole antibiotics |
US4610978A (en) | 1983-03-22 | 1986-09-09 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Compositions containing 1α-hydroxycholecalciferol for topical treatment of skin disorders and methods employing same |
JP2522962B2 (ja) * | 1986-09-19 | 1996-08-07 | 中外製薬株式会社 | 乾癬治療剤 |
US4847071A (en) * | 1987-10-22 | 1989-07-11 | The Procter & Gamble Company | Photoprotection compositions comprising tocopherol sorbate and an anti-inflammatory agent |
GB8821129D0 (en) * | 1988-09-09 | 1988-10-12 | Unilever Plc | Cosmetic composition |
GB9004544D0 (en) * | 1990-03-01 | 1990-04-25 | Leo Pharm Prod Ltd | Novel treatment ii |
US5087620A (en) * | 1990-05-17 | 1992-02-11 | Bristol-Myers Squibb Co. | Controlled dermal penetration enhancement using imidazoles |
US5185150A (en) * | 1990-08-24 | 1993-02-09 | Wisconsin Alumni Research Fdn. | Cosmetic compositions containing 19-nor-vitamin D compounds |
IL99368A (en) | 1991-09-02 | 1996-01-19 | Teva Pharma | Preparations for the treatment of psoriasis and atopic dermatitis, which contain the result of xanthine |
GB9226860D0 (en) | 1992-12-23 | 1993-02-17 | Leo Pharm Prod Ltd | Novel treatment |
USRE39706E1 (en) * | 1993-01-15 | 2007-06-26 | Leo Pharma A/S | Crystalline form of a vitamin D analogue |
GB9314400D0 (en) * | 1993-07-12 | 1993-08-25 | Leo Pharm Prod Ltd | Produktionsaktieselskab) chemical compounds |
JPH07173053A (ja) * | 1993-12-20 | 1995-07-11 | Otsuka Pharmaceut Co Ltd | 抗微生物剤 |
JP3506474B2 (ja) * | 1994-01-07 | 2004-03-15 | 帝人株式会社 | 安定性の向上した乾癬治療剤 |
TW460296B (en) * | 1994-09-01 | 2001-10-21 | Janssen Pharmaceutica Nv | Topical ketoconazole emulsion compositions without sodium sulfite |
US5840925A (en) * | 1995-06-29 | 1998-11-24 | Hauser, Inc. | Trioxane dimer compounds having antiproliferative and antitumor activities |
EP0897300A4 (en) * | 1995-10-10 | 2000-07-05 | Marilyn Strube | TREATMENT OF PRURITUS WITH VITAMIN D AND ITS ANALOGS |
FR2740042B1 (fr) * | 1995-10-23 | 1997-11-14 | Oreal | Support, et composition contenant ce support et un actif cosmetique ou dermatologique stabilise |
SG70009A1 (en) * | 1996-05-23 | 2000-01-25 | Hoffmann La Roche | Vitamin d3 analogs |
JPH1067757A (ja) * | 1996-06-21 | 1998-03-10 | Ss Pharmaceut Co Ltd | トリアゾール誘導体またはその塩 |
JPH10139669A (ja) * | 1996-11-05 | 1998-05-26 | Teijin Ltd | 脂漏性角化症治療剤 |
AU744471B2 (en) * | 1997-05-16 | 2002-02-21 | Women & Infants Hospital | 3-epi vitamin D2 compounds and uses thereof |
US6100294A (en) * | 1997-05-16 | 2000-08-08 | Women And Infants Hospital | Cyclic ether vitamin D3 compounds, 1α(OH) 3-epi-vitamin D3 compounds and uses thereof |
JP4387465B2 (ja) * | 1997-12-09 | 2009-12-16 | 中外製薬株式会社 | ビタミンd3誘導体を含有するローション剤 |
EP1040832A4 (en) * | 1997-12-09 | 2001-09-12 | Chugai Pharmaceutical Co Ltd | VITAMIN D3 CONTAINING CREAMS |
JPH11188054A (ja) * | 1997-12-25 | 1999-07-13 | Lion Corp | 皮膚外用部材 |
JPH11246329A (ja) * | 1998-02-27 | 1999-09-14 | Shiseido Co Ltd | 皮膚外用剤 |
RU2207843C2 (ru) * | 1998-03-04 | 2003-07-10 | Тейдзин Лимитед | Эмульсионный лосьон с активным витамином d3 |
US5886038A (en) * | 1998-03-24 | 1999-03-23 | Panda Pharmaceuticals, L.L.C. | Composition and method for treatment of psoriasis |
US5990100A (en) * | 1998-03-24 | 1999-11-23 | Panda Pharmaceuticals, L.L.C. | Composition and method for treatment of psoriasis |
HU230045B1 (hu) | 1999-04-23 | 2015-06-29 | Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) | Bőrgyógyászati alkalmazásra szolgáló nem vizes gyógyszerkészítmény |
-
2000
- 2000-01-27 HU HU0200879A patent/HU230045B1/hu unknown
- 2000-01-27 RS YU75701A patent/RS52182B/sr unknown
- 2000-01-27 SI SI200031093T patent/SI2915534T1/sl unknown
- 2000-01-27 EP EP11196069.6A patent/EP2450043B1/en not_active Revoked
- 2000-01-27 ES ES00901483T patent/ES2388425T5/es not_active Expired - Lifetime
- 2000-01-27 CA CA002370565A patent/CA2370565C/en not_active Expired - Lifetime
- 2000-01-27 SI SI200031072T patent/SI1178808T1/sl unknown
- 2000-01-27 SK SK1518-2001A patent/SK287653B6/sk not_active IP Right Cessation
- 2000-01-27 EP EP00901483.8A patent/EP1178808B2/en not_active Expired - Lifetime
- 2000-01-27 CN CNB008076677A patent/CN1173703C/zh not_active Expired - Lifetime
- 2000-01-27 DK DK00901483.8T patent/DK1178808T4/da active
- 2000-01-27 BR BR122012030847-1A patent/BR122012030847B1/pt not_active IP Right Cessation
- 2000-01-27 WO PCT/DK2000/000033 patent/WO2000064450A1/en active IP Right Grant
- 2000-01-27 LT LTEP14187329.9T patent/LT2915534T/lt unknown
- 2000-01-27 SI SI200031094T patent/SI3146969T1/en unknown
- 2000-01-27 PT PT111960696T patent/PT2450043T/pt unknown
- 2000-01-27 ES ES11196067T patent/ES2432691T3/es not_active Expired - Lifetime
- 2000-01-27 ES ES11196069.6T patent/ES2602450T3/es not_active Expired - Lifetime
- 2000-01-27 JP JP2000613441A patent/JP4426729B2/ja not_active Expired - Lifetime
- 2000-01-27 PT PT16185207T patent/PT3146969T/pt unknown
- 2000-01-27 DK DK11196067.0T patent/DK2455083T3/da active
- 2000-01-27 US US09/959,367 patent/US6753013B1/en not_active Expired - Lifetime
- 2000-01-27 AU AU22783/00A patent/AU774600B2/en not_active Expired
- 2000-01-27 ES ES16185207.4T patent/ES2674563T3/es not_active Expired - Lifetime
- 2000-01-27 EP EP11196067.0A patent/EP2455083B1/en not_active Expired - Lifetime
- 2000-01-27 CZ CZ20013739A patent/CZ303142B6/cs not_active IP Right Cessation
- 2000-01-27 BR BR122012030846A patent/BR122012030846B8/pt not_active IP Right Cessation
- 2000-01-27 ES ES14187329.9T patent/ES2671785T3/es not_active Expired - Lifetime
- 2000-01-27 EP EP14187329.9A patent/EP2915534B1/en not_active Expired - Lifetime
- 2000-01-27 KR KR1020017013576A patent/KR100694526B1/ko active IP Right Review Request
- 2000-01-27 PT PT00901483T patent/PT1178808E/pt unknown
- 2000-01-27 NZ NZ515142A patent/NZ515142A/xx not_active IP Right Cessation
- 2000-01-27 ME MEP-2008-391A patent/ME00298B/me unknown
- 2000-01-27 PT PT111960670T patent/PT2455083E/pt unknown
- 2000-01-27 RU RU2001131558A patent/RU2238734C2/ru active
- 2000-01-27 DK DK11196069.6T patent/DK2450043T3/en active
- 2000-01-27 BR BRPI0009956-2B1 patent/BRPI0009956B8/pt not_active IP Right Cessation
- 2000-01-27 EP EP16185207.4A patent/EP3146969B1/en not_active Expired - Lifetime
- 2000-01-27 PL PL351387A patent/PL199123B1/pl unknown
- 2000-01-27 MX MXPA01010676A patent/MXPA01010676A/es active IP Right Grant
- 2000-01-27 PT PT141873299T patent/PT2915534T/pt unknown
- 2000-01-27 LT LTEP16185207.4T patent/LT3146969T/lt unknown
- 2000-01-27 DK DK16185207.4T patent/DK3146969T3/en active
- 2000-01-27 DK DK14187329.9T patent/DK2915534T3/en active
- 2000-01-27 IL IL14598300A patent/IL145983A0/xx active IP Right Grant
-
2001
- 2001-10-16 IL IL145983A patent/IL145983A/en not_active IP Right Cessation
- 2001-10-19 BG BG106030A patent/BG65115B1/bg unknown
- 2001-10-22 IS IS6120A patent/IS6120A/is unknown
- 2001-10-23 HR HR20010779A patent/HRP20010779B1/xx not_active IP Right Cessation
- 2001-10-23 NO NO20015175A patent/NO329486B1/no not_active IP Right Cessation
-
2002
- 2002-09-26 HK HK02107078.8A patent/HK1045650B/zh unknown
-
2008
- 2008-07-24 JP JP2008191182A patent/JP5721926B2/ja not_active Expired - Lifetime
-
2012
- 2012-07-31 CY CY20121100676T patent/CY1113967T1/el unknown
-
2013
- 2013-01-29 JP JP2013014098A patent/JP2013075923A/ja active Pending
- 2013-09-19 CY CY20131100822T patent/CY1114420T1/el unknown
-
2015
- 2015-04-27 JP JP2015090105A patent/JP5886999B2/ja not_active Expired - Lifetime
-
2016
- 2016-10-19 CY CY20161101042T patent/CY1118206T1/el unknown
-
2018
- 2018-06-08 CY CY20181100600T patent/CY1120313T1/el unknown
- 2018-09-04 CY CY181100924T patent/CY1120659T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SK287653B6 (sk) | Nevodná farmaceutická kompozícia na dermálne použitie | |
US6787529B2 (en) | Topical composition | |
AU2001291637A1 (en) | Topical composition containing at least one vitamin D or one vitamin D analogue and at least one corticosteroid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK4A | Expiry of patent |
Expiry date: 20200127 |